Download pdf
Neurotransmitter Dysregulation in Sleep and Circadian Rhythms: Implications for Postpartum Depression
- 1 Georgia Institute of Technology
* Author to whom correspondence should be addressed.
Abstract
Postpartum depression (PPD) is a major mental health disorder that affects mothers both emotionally and physically, hindering their ability to care for the child. Other neurotransmitter imbalances during the postpartum period include serotonin, dopamine, melatonin, GABA, and orexin, which result in disturbances in sleep. The reduction in serotonin concentration is related to mood and sleep, while altered dopamine levels are related to alertness and coordinating circadian rhythms. Further, women postpartum demonstrates higher melatonin levels and a subsequent neuronal excitation due to lesser functioning GABA-A receptors, which in addition combine to cause disturbances with sleep. This paper reviews the literature to analyze the effects of neurotransmitter disorders in sleep and circadian rhythm on postpartum depression. The review provides emerging treatment options for postpartum depression including selective serotonin reuptake inhibitors (SSRIs), melatonin agonists, and benzodiazepines, which have shown promising results in relieving symptoms by modulating neurotransmitter pathways. However, more research needs to be undertaken in the field of non-pharmacological interventions, the long-term outcome of neurotransmitter dysregulation, and preventive measures during pregnancy that would go a long way toward improving overall outcomes for mothers as well as their infants.
Keywords
Postpartum depression (PPD), Sleep and Circadian Rhythms, Neurotransmitter Dysregulation.
[1]. Stewart, D. E., & Vigod, S. (2016). Postpartum Depression. New England Journal of Medicine, 375(22), 2177–2186.
[2]. O’Hara, M. W., & McCabe, J. E. (2013). Postpartum Depression: Current Status and Future Directions. Annual Review of Clinical Psychology, 9(1), 379–407.
[3]. MURRAY, L., & COOPER, P. J. (1997). Effects of postnatal depression on infant development. Archives of Disease in Childhood, 77(2), 99–101.
[4]. Field, T. (2010). Postpartum depression effects on early interactions, parenting, and safety practices: A review. Infant Behavior and Development, 33(1), 1–6.
[5]. Laposky, A. D., Bass, J., Kohsaka, A., & Turek, F. W. (2007). Sleep and circadian rhythms: Key components in the regulation of energy metabolism. FEBS Letters, 582(1), 142–151.
[6]. Czeisler, C. A., & Gooley, J. J. (2007). Sleep and Circadian Rhythms in Humans. Cold Spring Harbor Symposia on Quantitative Biology, 72(1), 579–597.
[7]. YAMANAKA, Y., HONMA, K., HASHIMOTO, S., TAKASU, N., MIYAZAKI, T., & HONMA, S. (2006). Effects of physical exercise on human circadian rhythms. Sleep and Biological Rhythms, 4(3), 199–206.
[8]. Kim, T. W., Jeong, J.-H., & Hong, S.-C. (2015). The Impact of Sleep and Circadian Disturbance on Hormones and Metabolism. International Journal of Endocrinology, 2015, 1–9.
[9]. Markov, D., & Goldman, M. (2006). Normal Sleep and Circadian Rhythms: Neurobiologic Mechanisms Underlying Sleep and Wakefulness. Psychiatric Clinics of North America, 29(4), 841–853.
[10]. Skalkidou A, Hellgren C, Comasco E, Sylvén S, Poromaa IS. Biological Aspects of Postpartum Depression. Women’s Health. 2012;8(6):659-672.
[11]. Pontes, A. L. B. de, Engelberth, R. C. G. J., Nascimento, E. da S., Cavalcante, J. C., Costa, M. S. M. de O., Pinato, L., … Cavalcante, J. de S. (2010). Serotonin and circadian rhythms. Psychology & Neuroscience, 3(2), 217–228.
[12]. Ursin, R. (2002). Serotonin and sleep. Sleep Medicine Reviews, 6(1), 55–67.
[13]. Barassin, S., Raison, S., Saboureau, M., Bienvenu, C., Maître, M., Malan, A., & Pévet, P. (2002). Circadian tryptophan hydroxylase levels and serotonin release in the suprachiasmatic nucleus of the rat. European Journal of Neuroscience, 15(5), 833–840.
[14]. Moore, R. Y., & Speh, J. C. (2004). Serotonin innervation of the primate suprachiasmatic nucleus. Brain Research, 1010(1-2), 169–173.
[15]. Yildiz, G., Senturk, M. B., Yildiz, P., Cakmak, Y., Budak, M. S., & Cakar, E. (2017). Serum serotonin, leptin, and adiponectin changes in women with postpartum depression: controlled study. Archives of Gynecology and Obstetrics, 295(4), 853–858.
[16]. Korshunov, K. S., Blakemore, L. J., & Trombley, P. Q. (2017). Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System. Frontiers in Cellular Neuroscience, 11.
[17]. Imbesi, M., Yildiz, S., Arslan, A. D., Sharma, R., Manev, H., and Uz, T. (2009). Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience 158, 537–544.
[18]. Post, C., & Leuner, B. (2018). The maternal reward system in postpartum depression. Archives of Women’s Mental Health, 22(3), 417–429.
[19]. TUREK, F., & GILLETTE, M. (2004). Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. Sleep Medicine, 5(6), 523–532.
[20]. Dubocovich, M. L. (2007). Melatonin receptors: Role on sleep and circadian rhythm regulation. Sleep Medicine, 8, 34–42.
[21]. Cajochen, C., Kräuchi, K., & Wirz-Justice, A. (2003). Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep. Journal of Neuroendocrinology, 15(4), 432–437.
[22]. Parry, B. L., Meliska, C. J., Sorenson, D. L., Lopez, A. M., Martinez, L. F., Nowakowski, S., … Kripke, D. F. (2008). Plasma Melatonin Circadian Rhythm Disturbances During Pregnancy and Postpartum in Depressed Women and Women With Personal or Family Histories of Depression. American Journal of Psychiatry, 165(12), 1551–1558.
[23]. Hepsomali, P., Groeger, J. A., Nishihira, J., & Scholey, A. (2020). Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review. Frontiers in Neuroscience, 14.
[24]. Meltzer-Brody, S., & Kanes, S. J. (2020). Allopregnanolone in Postpartum Depression: Role in Pathophysiology and Treatment. Neurobiology of Stress, 100212.
[25]. Maguire, J., & Mody, I. (2008). GABAAR Plasticity during Pregnancy: Relevance to Postpartum Depression. Neuron, 59(2), 207–213.
[26]. Ohno, K., & Sakurai, T. (2008). Orexin neuronal circuitry: Role in the regulation of sleep and wakefulness. Frontiers in Neuroendocrinology, 29(1), 70–87.
[27]. Mieda, M., & Sakurai, T. (2012). Overview of orexin/hypocretin system. Orexin/Hypocretin System, 5–14.
[28]. Nishino, S., Ripley, B., Overeem, S., Lammers, G. J., & Mignot, E. (2000). Hypocretin (orexin) deficiency in human narcolepsy. The Lancet, 355, 39–40.
[29]. Taheri S, Gardiner J, Hafizi S, Murphy K, Dakin C, Seal L, Small C, Ghatei M, Bloom S. Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats. Neuroreport 2001;12(3):459–464.
[30]. Zisapel, N. (2001). Cellular and Molecular Neurobiology, 21(6), 605–616.
[31]. Bloch, M., Daly, R. C. & Rubinow, D. R. Endocrine factors in the etiology of postpartum depression. Compr. Psychiatry 44, 234–246 (2003).
[32]. Tadavarty, R., Rajput, P. S., Wong, J. M., Kumar, U., & Sastry, B. R. (2011). Sleep-Deprivation Induces Changes in GABAB and mGlu Receptor Expression and Has Consequences for Synaptic Long-Term Depression. PLoS ONE, 6(9), e24933.
[33]. Hendrick, V., Altshuler, L. L., & Suri, R. (1998). Hormonal Changes in the Postpartum and Implications for Postpartum Depression. Psychosomatics, 39(2), 93–101.
[34]. Nott PN, Franklin M, Armitage C, et al: Hormonal changes and mood in the puerperium. Br J Psychiatry 1976; 128:379–383
[35]. Ravagnati, L., Halgren, E., Babb, T. L., & Crandall, P. H. (1979). Activity of Human Hippocampal Formation and Amygdala Neurons During Sleep. Sleep, 2(2), 161–173.
[36]. Barth, C., Villringer, A., & Sacher, J. (2015). Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Frontiers in Neuroscience, 9. doi:10.3389/fnins.2015.00037
[37]. Glynn, L. M., Davis, E. P., & Sandman, C. A. (2013). New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Neuropeptides, 47(6), 363–370.
[38]. Garcia-Leal, C., De Rezende, M. G., Corsi-Zuelli, F. M. das G., De Castro, M., & Del-Ben, C. M. (2017). The functioning of the hypothalamic-pituitary-adrenal (HPA) axis in postpartum depressive states: a systematic review. Expert Review of Endocrinology & Metabolism, 12(5), 341–353.
[39]. Braquehais, M. D., Picouto, M. D., Casas, M., & Sher, L. (2012). Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide. World Journal of Pediatrics, 8(3), 197–206.
[40]. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry. 1999;60 Suppl 17:28-31; discussion 46-8. PMID: 10446739.
[41]. Banzi, R., Cusi, C., Randazzo, C., Sterzi, R., Tedesco, D., & Moja, L. (2015). Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. Cochrane Database of Systematic Reviews
[42]. Williams, W. P. T., McLin, D. E., Dressman, M. A., & Neubauer, D. N. (2016). Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(9), 1028–1041.
[43]. Atack, J. R. (2010). Development of Subtype-Selective GABAA Receptor Compounds for the Treatment of Anxiety, Sleep Disorders and Epilepsy. GABA and Sleep, 25–72.
[44]. Fitelson, E., Kim, S., Baker, A. S., & Leight, K. (2010). Treatment of postpartum depression: clinical, psychological and pharmacological options. International Journal of Women’s Health, 3, 1–14.
Cite this article
Wang,X. (2024). Neurotransmitter Dysregulation in Sleep and Circadian Rhythms: Implications for Postpartum Depression. Theoretical and Natural Science,66,43-49.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).